Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T15:12:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error. The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:51:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T15:12:02.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record with a minimal error screen and navigation header.
    Difference
    18%
    Check dated 2026-09-19T22:27:11.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    An NIH funding note '2018 ( U.S. NIH Grant/Contract )' was added and a new page revision tag 'Revision: v3.6.6' was introduced, while the 'Plain Language Summary' and the previous revision tag 'Revision: v3.6.5' were removed.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:08.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a new build of the site.
    Difference
    0.0%
    Check dated 2026-08-08T18:21:06.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.